What is the expected market size of the Japan Dysmenorrhea Treatment Market in 2024?

The Japan Dysmenorrhea Treatment Market is expected to be valued at 153.0 million USD in 2024. Read More

What is the projected market value of the Japan Dysmenorrhea Treatment Market by 2035?

By 2035, the market is projected to reach a value of 585.0 million USD. Read More

What is the expected CAGR for the Japan Dysmenorrhea Treatment Market from 2025 to 2035?

The market is expected to grow at a CAGR of 12.967 percent during the period from 2025 to 2035. Read More

Which product type holds a dominant market share within the Japan Dysmenorrhea Treatment Market?

Primary Dysmenorrhea is expected to dominate the market with a valuation of 90.0 million USD in 2024. Read More

What will be the market size for Primary Dysmenorrhea by 2035?

The market for Primary Dysmenorrhea is anticipated to grow to 345.0 million USD by 2035. Read More

How much is the Secondary Dysmenorrhea market valued at in 2024?

In 2024, the market for Secondary Dysmenorrhea is valued at 63.0 million USD. Read More

What is the projected market size for Secondary Dysmenorrhea by 2035?

The market for Secondary Dysmenorrhea is expected to reach about 240.0 million USD by 2035. Read More

Who are the key players in the Japan Dysmenorrhea Treatment Market?

Key players include Fujifilm Corporation, Takeda Pharmaceutical Company, Astellas Pharma, and Novartis, among others. Read More

What are the growth opportunities in the Japan Dysmenorrhea Treatment Market?

The market offers growth opportunities in terms of innovation in treatment options and increasing awareness among women. Read More

What are the challenges facing the Japan Dysmenorrhea Treatment Market?

Challenges include the need for effective marketing strategies and addressing potential side effects associated with treatments. Read More

Japan Dysmenorrhea Treatment Market

ID: MRFR/MED/52777-HCR

200 Pages

Rahul Gotadki

Last Updated: March 28, 2026

Japan Dysmenorrhea Treatment Market Research Report: Size, Share, Trend Analysis By Product Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), By Types of Treatment (Pain Relievers, Hormonal Therapy, Surgery), andBy End-User (Hospitals & Clinics, Research Centers) - Growth Outlook & Industry Forecast 2025 To 2035

Japan Dysmenorrhea Treatment Market Infographic

Summary Table of Contents Segmentation Download PDF

1 EXECUTIVE SUMMARY
1. Market Overview
2. 1.2 Key Findings
3. 1.3 Market Segmentation
4. Competitive Landscape
5. 1.5 Challenges and Opportunities
6. 1.6 Future
7. Outlook
2 MARKET INTRODUCTION
1. 2.1 Definition
2. 2.2 Scope of the study
  1. 2.2.1 Research Objective
  2. 2.2.2 Assumption
  3. 2.2.3 Limitations
3 RESEARCH METHODOLOGY
1. 3.1 Overview
2. Data Mining
3. 3.3 Secondary Research
4. 3.4 Primary Research
  1. 3.4.2 Breakdown of Primary
5. Primary Interviews and Information Gathering Process
6. Respondents
7. 3.5 Forecasting Model
8. 3.6 Market Size Estimation
  1. 3.6.2 Top-Down Approach
9. Bottom-Up Approach
10. 3.7 Data Triangulation
11. 3.8 Validation
4 MARKET DYNAMICS
1. 4.1 Overview
2. 4.2 Drivers
3. 4.3 Restraints
4. 4.4 Opportunities
5 MARKET
FACTOR ANALYSIS
1. 5.1 Value chain Analysis
2. 5.2 Porter's Five Forces
  1. 5.2.1 Bargaining Power of Suppliers
  2. 5.2.2 Bargaining Power
  3. 5.2.3 Threat of New Entrants
  4. 5.2.4 Threat of Substitutes
  5. 5.2.5 Intensity of Rivalry
3. Analysis
4. of Buyers
5. 5.3 COVID-19 Impact Analysis
  1. 5.3.2 Regional Impact
  2. 5.3.3 Opportunity and
6. Market Impact Analysis
7. Threat Analysis
6 Japan Dysmenorrhea Treatment Market,
1. BY PRODUCT TYPE (USD MILLION)
2. 6.1 Primary Dysmenorrhea
3. 6.2 Secondary
4. Dysmenorrhea
7 Japan Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT
1. (USD MILLION)
2. 7.1 Pain Relievers
3. 7.2 Hormonal Therapy
4. 7.3 Surgery
8 Japan Dysmenorrhea Treatment Market, BY END-USER (USD MILLION)
1. Hospitals & Clinics
2. 8.2 Research Centers
9 COMPETITIVE
1. LANDSCAPE
2. 9.1 Overview
3. 9.2 Competitive Analysis
4. 9.3 Market
5. share Analysis
6. 9.4 Major Growth Strategy in the Dysmenorrhea Treatment Market
7. 9.5 Competitive Benchmarking
8. 9.6 Leading Players in Terms of Number
9. of Developments in the Dysmenorrhea Treatment Market
10. 9.7 Key developments
  1. 9.7.1 New Product Launch/Service Deployment
  2. 9.7.3 Joint Ventures
11. and growth strategies
12. Merger & Acquisitions
13. 9.8 Major Players Financial
  1. 9.8.1 Sales and Operating Income
  2. 9.8.2 Major Players R&D
14. Matrix
15. Expenditure. 2023
10 COMPANY PROFILES
1. 10.1 Fujifilm Corporation
  1. 10.1.1 Financial Overview
  2. 10.1.2 Products Offered
  3. 10.1.3 Key Developments
  4. 10.1.4 SWOT Analysis
  5. 10.1.5 Key Strategies
2. 10.2 Takeda Pharmaceutical
  1. 10.2.1 Financial Overview
  2. 10.2.2 Products Offered
  3. 10.2.4 SWOT Analysis
  4. 10.2.5 Key Strategies
  5. 10.3.1 Financial Overview
  6. 10.3.2 Products Offered
  7. 10.3.3 Key Developments
  8. 10.3.4 SWOT Analysis
  9. 10.3.5 Key Strategies
3. Company
4. Key Developments
5. Astellas Pharma
6. 10.4 Novartis
  1. 10.4.1 Financial Overview
  2. 10.4.2 Products Offered
  3. 10.4.3 Key Developments
  4. 10.4.4 SWOT Analysis
  5. 10.4.5 Key Strategies
7. 10.5 Sanofi
  1. 10.5.1 Financial Overview
  2. 10.5.2 Products Offered
  3. 10.5.3 Key Developments
  4. 10.5.4 SWOT Analysis
  5. 10.5.5 Key Strategies
8. 10.6 Eisai Co
  1. 10.6.1 Financial Overview
  2. 10.6.2 Products Offered
  3. 10.6.3 Key Developments
  4. 10.6.4 SWOT Analysis
  5. 10.6.5 Key Strategies
9. 10.7 Johnson & Johnson
  1. 10.7.1 Financial Overview
  2. 10.7.3 Key Developments
  3. 10.7.4 SWOT Analysis
  4. 10.7.5 Key Strategies
10. Products Offered
11. 10.8 Pfizer
  1. 10.8.1 Financial Overview
  2. 10.8.2 Products Offered
  3. 10.8.3 Key Developments
  4. 10.8.4 SWOT Analysis
  5. 10.8.5 Key Strategies
12. 10.9 Merck & Co
  1. 10.9.1 Financial
  2. 10.9.2 Products Offered
  3. 10.9.3 Key Developments
  4. 10.9.5 Key Strategies
13. Overview
14. SWOT Analysis
15. 10.10 AbbVie
  1. 10.10.1 Financial
  2. 10.10.2 Products Offered
  3. 10.10.3 Key Developments
  4. 10.10.5 Key Strategies
16. Overview
17. SWOT Analysis
18. 10.11 Teva Pharmaceutical Industries
  1. 10.11.1 Financial Overview
  2. 10.11.2 Products Offered
  3. 10.11.4 SWOT Analysis
  4. 10.11.5 Key Strategies
19. Key Developments
20. 10.12 Bayer
  1. 10.12.1 Financial Overview
  2. 10.12.2 Products Offered
  3. 10.12.3 Key Developments
  4. 10.12.4 SWOT Analysis
  5. 10.12.5 Key
21. Strategies
22. 10.13 GlaxoSmithKline
  1. 10.13.1 Financial Overview
  2. 10.13.3 Key Developments
  3. 10.13.4 SWOT Analysis
  4. 10.13.5 Key Strategies
23. Products Offered
24. 10.14 Hikma Pharmaceuticals
  1. 10.14.1 Financial
  2. 10.14.2 Products Offered
  3. 10.14.3 Key Developments
  4. 10.14.5 Key Strategies
25. Overview
26. SWOT Analysis
27. 10.15 Mylan N.V.
  1. 10.15.2 Products Offered
  2. 10.15.3 Key Developments
  3. 10.15.4 SWOT Analysis
  4. 10.15.5 Key Strategies
28. Financial Overview
11 APPENDIX
1. 11.1 References
2. 11.2 Related Reports
LIST OF TABLES
1. TABLE
1 LIST OF ASSUMPTIONS
TABLE 2 JAPAN DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES
& Japan Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 3 JAPAN DYSMENORRHEA
TREATMENT MARKET SIZE ESTIMATES & Japan Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019-2035
1. (USD BILLIONS)
TABLE 4 JAPAN DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES
& Japan Dysmenorrhea Treatment Market, BY END-USER, 2019-2035 (USD BILLIONS)
TABLE 5 PRODUCT LAUNCH/PRODUCT
1. DEVELOPMENT/APPROVAL
TABLE 6 ACQUISITION/PARTNERSHIP
1. LIST OF
2. FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN DYSMENORRHEA
1. TREATMENT MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 3 JAPAN DYSMENORRHEA TREATMENT
1. MARKET ANALYSIS BY TYPE OF TREATMENT
FIGURE 4 JAPAN DYSMENORRHEA TREATMENT
1. MARKET ANALYSIS BY END-USER
FIGURE 5 KEY BUYING CRITERIA OF DYSMENORRHEA
TREATMENT MARKET
FIGURE 6 RESEARCH PROCESS OF MRFR
FIGURE 7 DRO ANALYSIS
OF DYSMENORRHEA TREATMENT MARKET
FIGURE 8 DRIVERS IMPACT ANALYSIS: DYSMENORRHEA
TREATMENT MARKET
FIGURE 9 RESTRAINTS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT
1. MARKET
FIGURE 10 SUPPLY / VALUE CHAIN: DYSMENORRHEA TREATMENT MARKET
FIGURE 11 Japan Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2025 (% SHARE)
FIGURE 12 Japan Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
FIGURE 13 Japan Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2025 (% SHARE)
FIGURE 14 Japan Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019 TO 2035
1. (USD Billions)
FIGURE 15 Japan Dysmenorrhea Treatment Market, BY END-USER, 2025
1. (% SHARE)
FIGURE 16 Japan Dysmenorrhea Treatment Market, BY END-USER, 2019 TO 2035
1. (USD Billions)
FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS

Certified Researchers

Customize Report

Japan Dysmenorrhea Treatment Market Segmentation

Japan Dysmenorrhea Treatment Market By Product Type (USD Million, 2019-2035)
- Primary Dysmenorrhea
- Secondary Dysmenorrhea

Japan Dysmenorrhea Treatment Market By Type of Treatment (USD Million, 2019-2035)
- Pain Relievers
- Hormonal Therapy
- Surgery

Japan Dysmenorrhea Treatment Market By End-User (USD Million, 2019-2035)
- Hospitals & Clinics
- Research Centers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓

Japan Dysmenorrhea Treatment Market

Japan Dysmenorrhea Treatment Market Segmentation

Japan Dysmenorrhea Treatment Market By Product Type (USD Million, 2019-2035)

Japan Dysmenorrhea Treatment Market By Type of Treatment (USD Million, 2019-2035)

Japan Dysmenorrhea Treatment Market By End-User (USD Million, 2019-2035)

Related Reports

Customer Stories

Aerospace & Defense

Compare Licence